-

Owens & Minor Wins Seventh Premier GPO Supplier Legacy Award

Award recognizes Owens & Minor’s long-standing, consistent support of Premier’s nationwide membership of hospitals, health systems and other providers

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI), a leading global healthcare solutions company, today announced that it recently received the 2022 Supplier Legacy Award from Premier Inc. The award recognizes Owens & Minor’s long-standing history of consistently supporting Premier network members. Owens & Minor leadership was in attendance at Premier’s annual Breakthrough Awards, June 21—23, to receive the award.

“We know the complexities faced by hospitals, health systems and other providers as they strive to deliver excellent clinical care for their patients while also responsibly managing costs,” commented Edward A. Pesicka, President and CEO, Owens & Minor. “We’re proud to be recognized by Premier and its members for consistently and reliably supporting their efforts in attaining those goals. Through our product manufacturing and broad supply services, Owens & Minor remains laser focused on supporting Premier and its members, like all Owens & Minor customers, as we fulfill our mission of Empowering Our Customers to Advance Healthcare. This award is dedicated with gratitude to our incredible teammates around the world that support our customers every day.”

This year marks the seventh that Owens & Minor has received the Premier Supplier Legacy Award. Owens & Minor was also previously recognized by Premier in 2021 with its COVID-19 Award for Most Supportive Supplier in recognition of the company’s rapid response during the earliest days of the pandemic, implementing robust safety protocols and ramping up Owens & Minor’s Americas-based PPE manufacturing to help maintain supply resiliency.

“Owens & Minor supports Premier members by offering valuable products and services that help to lower supply chain costs and improve operating efficiencies,” said David A. Hargraves, Senior Vice President, Supply Chain, Premier. “We’re honored to recognize them as a Legacy Award recipient.”

Learn more about how Owens & Minor is helping healthcare customers through its industry-leading distribution and supply chain solutions at https://www.owens-minor.com/distribution/.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company integrating product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. Owens & Minor drives visibility, control and efficiency for patients, providers and healthcare professionals across the supply chain with proprietary technology and solutions, an extensive product portfolio, an Americas-based manufacturing footprint for personal protective equipment (PPE) and surgical products, as well as a robust portfolio of products and services for patients managing chronic and acute conditions in the home setting. Operating continuously since 1882 from its headquarters in Richmond, Va., Owens & Minor is a 140-year-old company powered by more than 20,000 global teammates. Learn more at https://www.owens-minor.com, follow @Owens_Minor on Twitter and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.

Contacts

Media Relations for Owens & Minor:
Stacy Law
media@owens-minor.com

Owens & Minor, Inc.

NYSE:ACH
Details
Headquarters: Richmond, VA
CEO: Edward Pesicka
Employees: 6000
Organization: PUB

Release Summary
Owens & Minor won its seventh Supplier Legacy Award for its consistent, long-time support of Premier's hospital, health system and provider members.
Release Versions

Contacts

Media Relations for Owens & Minor:
Stacy Law
media@owens-minor.com

Social Media Profiles
More News From Owens & Minor, Inc.

Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the expiration and final results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). As of 5:00 P.M., New York City time, on June 23, 2026 (the “Expiration Time”), the Company received...

Accendra Health Announces Early Results of Offers and Consent Solicitations

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the early results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). Eligible Holders of 2029 Notes that participate in the New Money Notes Issuance (as defined below) will be able to...

Accendra Health Announces Offers and Consent Solicitations

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it has commenced an offer to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). Eligible Holders of 2029 Notes that participate in the New Money Notes Issuance (as defined below) will be able to exchange such 2029 No...
Back to Newsroom